These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 20048219)

  • 21. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New-onset type-2 diabetes associated with atypical antipsychotic medications.
    Lambert MT; Copeland LA; Sampson N; Duffy SA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):919-23. PubMed ID: 16581171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
    Schneiderhan ME; Batscha CL; Rosen C
    Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of regulatory labeling for troglitazone and rosiglitazone on hepatic enzyme monitoring compliance: findings from the state of Ohio medicaid program.
    Cluxton RJ; Li Z; Heaton PC; Weiss SR; Zuckerman IH; Moomaw CJ; Hsu VD; Rodriguez EM
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):1-9. PubMed ID: 15546159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.
    Baker RA; Pikalov A; Tran QV; Kremenets T; Arani RB; Doraiswamy PM
    Psychopharmacol Bull; 2009; 42(1):11-31. PubMed ID: 19204649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal glucose metabolism in patients treated with antipsychotics.
    Scheen AJ; De Hert MA
    Diabetes Metab; 2007 Jun; 33(3):169-75. PubMed ID: 17412628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time to psychiatric hospitalization in patients with bipolar disorder treated with a mood stabilizer and adjunctive atypical antipsychotics: a retrospective claims database analysis.
    Kim E; Maclean R; Ammerman D; Jing Y; Pikalov A; You M; Van-Tran Q; L'Italien G
    Clin Ther; 2009 Apr; 31(4):836-48. PubMed ID: 19446157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metabolic side effects of second generation antipsychotics in drug-naïve patients: a preliminary study].
    Diurni M; Baranzini F; Costantini C; Poloni N; Vender S; Callegari C
    Riv Psichiatr; 2009; 44(3):176-8. PubMed ID: 20066804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of Recommended Metabolic Laboratory Parameters Among Medicaid Recipients on Second-Generation Antipsychotics in Federally Qualified Health Centers.
    Uzal NE; Chavez B; Kosirog ER; Billups SJ; Saseen JJ
    Ann Pharmacother; 2018 Feb; 52(2):160-165. PubMed ID: 28884591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics.
    DelMonte MT; Bostwick JR; Bess JD; Dalack GW
    J Clin Pharm Ther; 2012 Dec; 37(6):668-73. PubMed ID: 22845616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antipsychotic use and the risk of diabetes in nursing home residents with dementia.
    Jalbert JJ; Daiello LA; Eaton CB; Miller SC; Lapane KL
    Am J Geriatr Pharmacother; 2011 Jun; 9(3):153-63. PubMed ID: 21596626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Have antiepileptic drug prescription claims changed following the FDA suicidality warning? An evaluation in a state Medicaid program.
    Mittal M; Harrison DL; Miller MJ; Farmer KC; Thompson DM; Ng YT
    Epilepsy Behav; 2014 May; 34():109-15. PubMed ID: 24739448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].
    Verdoux H; Gaudron Y; Auleley GR; Deligne J; Blum-Boisgard C; Thiébaut A; Tournier M
    Encephale; 2013 May; 39 Suppl 1():S22-8. PubMed ID: 23246328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring metabolic side effects when initiating treatment with second-generation antipsychotic medication.
    Weissman E; Jackson C; Schooler N; Goetz R; Essock S
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):201-7. PubMed ID: 22182457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics and trends of low-dose quetiapine use in two western state Medicaid programs.
    Hartung DM; Zerzan J; Yamashita T; Tong S; Morden NE; Libby AM
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):87-94. PubMed ID: 24142840
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperlipidemia following treatment with antipsychotic medications.
    Olfson M; Marcus SC; Corey-Lisle P; Tuomari AV; Hines P; L'Italien GJ
    Am J Psychiatry; 2006 Oct; 163(10):1821-5. PubMed ID: 17012695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence of cardiovascular outcomes and diabetes mellitus among users of second-generation antipsychotics.
    Citrome L; Collins JM; Nordstrom BL; Rosen EJ; Baker R; Nadkarni A; Kalsekar I
    J Clin Psychiatry; 2013 Dec; 74(12):1199-206. PubMed ID: 24434088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study.
    van Winkel R; Moons T; Peerbooms O; Rutten B; Peuskens J; Claes S; van Os J; De Hert M
    Int Clin Psychopharmacol; 2010 Sep; 25(5):270-6. PubMed ID: 20523222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of death in elderly users of conventional vs. atypical antipsychotic medications.
    Wang PS; Schneeweiss S; Avorn J; Fischer MA; Mogun H; Solomon DH; Brookhart MA
    N Engl J Med; 2005 Dec; 353(22):2335-41. PubMed ID: 16319382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.